搜尋





搜尋





Zentalis Pharmaceuticals Inc

ZNTL

添加自選

2.750USD

-0.120-4.18%

收盤 09-24 16:00（美東）

195.77M總市值

虧損本益比TTM

Zentalis Pharmaceuticals Inc

2.750

-0.120-4.18%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

ZNTL 利潤表

您可以在這裡找到Zentalis Pharmaceuticals Inc的年度或季度收入報告，以深入了解Zentalis Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q1

營業總收入

----

-100.00%0.00

--0.00

-100.00%0.00

--26.86M

--0.00

--40.56M

----

營業收入

----

-100.00%0.00

--0.00

--26.86M

--0.00

----

營業費用

23.11%44.39M

3.22%37.85M

-48.76%37.39M

-34.41%33.73M

-44.65%36.06M

-43.86%36.67M

7.44%72.98M

-17.99%51.43M

11.65%65.15M

8.96%65.33M

31.24%67.92M

15.73%62.72M

-8.06%58.35M

3.58%59.95M

7.39%51.75M

0.23%54.19M

15.11%63.46M

14.96%57.88M

19.75%48.19M

55.52%54.07M

101.39%55.13M

207.01%50.35M

--40.24M

--34.77M

--27.38M

88.02%16.40M

--8.72M

研發費用

27.36%35.16M

10.04%28.72M

-10.57%29.49M

-37.68%22.95M

-42.94%27.61M

-47.37%26.09M

-36.05%32.97M

-21.26%36.82M

13.36%48.39M

2.06%49.59M

26.94%51.56M

10.87%46.77M

-2.60%42.68M

5.36%48.58M

5.66%40.62M

-6.68%42.18M

-2.11%43.83M

20.10%46.11M

30.21%38.44M

83.21%45.20M

156.53%44.77M

189.59%38.39M

--29.52M

--24.67M

--17.45M

87.02%13.26M

--7.09M

折舊攤銷及損耗

-4.38%153.00K

-42.37%151.00K

-52.13%157.00K

-54.02%160.00K

-51.07%160.00K

-19.14%262.00K

-5.75%328.00K

0.00%348.00K

-4.94%327.00K

-10.00%324.00K

-3.06%348.00K

-7.20%348.00K

-1.15%344.00K

4.65%360.00K

71.77%359.00K

173.72%375.00K

192.44%348.00K

335.44%344.00K

186.30%209.00K

168.63%137.00K

213.16%119.00K

107.89%79.00K

--73.00K

--51.00K

--38.00K

80.95%38.00K

--21.00K

營業利潤

-23.11%-44.39M

-3.22%-37.85M

18.91%-37.39M

34.41%-33.73M

44.65%-36.06M

-48.09%-36.67M

32.11%-46.11M

17.99%-51.43M

-11.65%-65.15M

58.69%-24.77M

-31.24%-67.92M

-15.73%-62.72M

8.06%-58.35M

-3.58%-59.95M

-7.39%-51.75M

-0.23%-54.19M

-15.11%-63.46M

-14.96%-57.88M

-19.75%-48.19M

-55.52%-54.07M

-101.39%-55.13M

-207.01%-50.35M

---40.24M

---34.77M

---27.38M

-88.02%-16.40M

---8.72M

淨非營業利息收入（費用）

利息收入

----

-12.80%143.00K

----

121.62%164.00K

--74.00K

出售證券收益

-75.58%2.24M

198.76%2.62M

20.58%2.62M

-37.38%7.04M

140.17%9.18M

-107.60%-2.66M

-68.28%2.17M

56.01%11.25M

-613.66%-22.86M

750.52%34.95M

111.88%6.85M

278.43%7.21M

949.76%4.45M

864.55%4.11M

3572.73%3.23M

1824.24%1.91M

268.70%424.00K

--426.00K

-72.06%88.00K

-17.50%99.00K

36.90%115.00K

----

--315.00K

--120.00K

--84.00K

----

特殊收入（費用）

--0.00

100.00%0.00

--0.00

---8.95M

---3.74M

--0.00

100.00%0.00

----

--0.00

---45.57M

---5.00M

--0.00

-100.00%0.00

----

--0.00

--42.78M

----

其他非經營性收入（費用）

----

---44.00K

----

100.00%0.00

---12.00K

稅前利潤

-56.84%-42.15M

27.02%-35.23M

27.06%-34.77M

33.58%-26.69M

69.47%-26.87M

-574.11%-48.28M

21.94%-47.68M

27.61%-40.19M

11.52%-88.01M

116.74%10.18M

-25.87%-61.07M

-6.16%-55.51M

-57.79%-99.47M

-5.90%-60.84M

-0.87%-48.52M

-367.32%-52.29M

-14.58%-63.04M

-14.34%-57.45M

-20.47%-48.10M

67.71%-11.19M

-101.59%-55.02M

-209.50%-50.25M

---39.93M

---34.65M

---27.29M

-87.47%-16.23M

---8.66M

所得稅

--138.00K

--120.00K

315.61%442.00K

100.00%0.00

-100.00%0.00

-51.85%-205.00K

-187.10%-27.00K

143.97%266.00K

32.41%143.00K

62.50%-135.00K

119.50%31.00K

-3658.82%-605.00K

227.27%108.00K

-326.42%-360.00K

77.19%-159.00K

-62.22%17.00K

-83.16%33.00K

-62.68%159.00K

-3972.22%-697.00K

--45.00K

--196.00K

--426.00K

--18.00K

----

--3.00K

除稅後的權益收益

----

--0.00

100.00%0.00

-156.73%-13.70M

-31.92%-2.31M

-272.58%-6.82M

---2.37M

---5.34M

---1.75M

---1.83M

----

除稅後利潤

-57.35%-42.29M

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-580.87%-48.28M

22.10%-47.47M

27.70%-40.16M

10.71%-88.28M

116.47%10.04M

-26.53%-60.94M

-6.54%-55.54M

-56.79%-98.86M

-6.03%-60.95M

0.21%-48.16M

-396.85%-52.13M

-14.51%-63.05M

-13.96%-57.49M

-19.60%-48.26M

69.73%-10.49M

-101.75%-55.06M

-210.71%-50.44M

---40.36M

---34.66M

---27.29M

-87.41%-16.23M

---8.66M

持續經營利潤

-57.35%-42.29M

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-580.87%-48.28M

22.10%-47.47M

27.70%-40.16M

21.58%-88.28M

115.87%10.04M

-10.83%-60.94M

-1.91%-55.54M

-64.59%-112.56M

-6.79%-63.26M

-9.76%-54.98M

-419.44%-54.50M

-24.21%-68.39M

-17.43%-59.24M

-24.13%-50.09M

69.73%-10.49M

-101.75%-55.06M

-210.71%-50.44M

---40.36M

---34.66M

---27.29M

-87.41%-16.23M

---8.66M

歸屬少數股東的淨利潤

----

--0.00

100.00%0.00

34.88%-28.00K

-69.23%-22.00K

87.88%-12.00K

-5.71%-37.00K

73.13%-43.00K

63.89%-13.00K

98.43%-99.00K

92.83%-35.00K

70.53%-160.00K

32.08%-36.00K

-5628.18%-6.30M

-12.18%-488.00K

-398.17%-543.00K

---53.00K

---110.00K

---435.00K

65.94%-109.00K

---320.00K

歸属于母公司的淨利潤

-57.35%-42.29M

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-579.53%-48.28M

22.07%-47.47M

27.68%-40.16M

21.55%-88.28M

115.93%10.07M

-10.82%-60.92M

-2.07%-55.53M

-64.62%-112.53M

-7.01%-63.22M

-9.81%-54.97M

-1198.04%-54.40M

-25.26%-68.36M

-18.39%-59.08M

-24.21%-50.06M

87.87%-4.19M

-103.20%-54.57M

-209.44%-49.90M

---40.30M

---34.55M

---26.86M

-93.29%-16.13M

---8.34M

歸屬普通股東的淨利潤

-57.35%-42.29M

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-579.53%-48.28M

22.07%-47.47M

27.68%-40.16M

21.55%-88.28M

115.93%10.07M

-10.82%-60.92M

-2.07%-55.53M

-64.62%-112.53M

-7.01%-63.22M

-9.81%-54.97M

-1198.04%-54.40M

-25.26%-68.36M

-18.39%-59.08M

-24.21%-50.06M

87.87%-4.19M

-103.20%-54.57M

-209.44%-49.90M

---40.30M

---34.55M

---26.86M

-93.29%-16.13M

---8.34M

基本每股收益

-58.82%-0.59

25.30%-0.50

26.22%-0.49

34.48%-0.37

69.96%-0.37

-574.30%-0.67

22.55%-0.67

28.19%-0.56

32.87%-1.24

113.32%0.14

9.05%-0.86

17.88%-0.79

-38.42%-1.85

18.32%-1.07

15.00%-0.95

-919.32%-0.96

0.18%-1.34

-5.61%-1.31

-10.47%-1.11

89.68%-0.09

-96.21%-1.34

-164.53%-1.24

---1.01

---0.91

---0.68

-93.28%-0.47

---0.24

稀釋每股收益

-58.82%-0.59

25.30%-0.50

26.22%-0.49

34.48%-0.37

69.96%-0.37

-576.28%-0.67

22.55%-0.67

28.19%-0.56

32.87%-1.24

113.26%0.14

9.05%-0.86

17.88%-0.79

-38.42%-1.85

18.32%-1.07

15.00%-0.95

-919.32%-0.96

0.18%-1.34

-5.61%-1.31

-10.47%-1.11

89.68%-0.09

-96.21%-1.34

-164.53%-1.24

---1.01

---0.91

---0.68

-93.28%-0.47

---0.24

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Zentalis Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 ZNTL 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Zentalis Pharmaceuticals Inc 全年的淨利潤是多少？



Zentalis Pharmaceuticals Inc 2025 財年淨利潤為 -137.06M。

Zentalis Pharmaceuticals Inc 上一季度的淨利潤是多少？



Zentalis Pharmaceuticals Inc 最近一個季度的淨利潤為 -42.29M。

Zentalis Pharmaceuticals Inc 年度營業利潤是多少？



Zentalis Pharmaceuticals Inc 2025 財年的營業利潤為 -145.01M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。